Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health

You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	862,440 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for concentrate for solution	36,112,482 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for concentrate for solution	15,070,636 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution	89,170,219 L.L
L01FD01	HERCEPTIN	BioTech	Trastuzumab - 440mg	21mg/ml	Injectable concentrated powder for solution+diluent	166,423,476 L.L
L01FD01	HERCEPTIN	BioTech	Trastuzumab - 440mg	21mg/ml	Injectable concentrated powder for solution+diluent	166,423,476 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution	1,462,608 L.L
A11CC05	HI DEE	G	Vitamin D3 - 50000IU	50000IU	Capsule, soft gelatin	518,723 L.L
A11CC05	HI DEE	G	Vitamin D3 - 5000IU	5000IU	Capsule, soft gelatin	740,457 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 1200IU, Blood Coagulation Factor VIII - 500IU		Injectable lyophilised powder for solution+diluent	32,710,519 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 2400IU, Blood Coagulation Factor VIII - 1000IU		Injectable lyophilised powder for solution+diluent	811,667 L.L
B02BD06	HAEMATE P	BioHuman	Von Willebrand Factor - 600IU, Blood Coagulation Factor VIII - 250IU		Injectable lyophilised powder for solution+diluent	13,703,903 L.L